Ingredion Q3 2022 Earnings Report
Key Takeaways
Ingredion's Q3 2022 results showed strong growth with net sales up 15%. The company successfully offset higher input costs and expanded gross margins, leading to strong operating income growth. Specialty ingredients continued to grow double digits across all regions.
Net sales increased by 15% due to solid demand and dynamic price management.
Specialty ingredients grew double digits, with higher net sales and gross profit margins across all regions.
The company commissioned a new production facility in Shandong, China, doubling local starch production capacity.
European Union approved Ingredion's bioconverted Reb M stevia solutions, supporting the sugar reduction growth platform.
Ingredion
Ingredion
Forward Guidance
Ingredion expects full-year 2022 reported EPS to be in the range of $6.90 to $7.20 and adjusted EPS to be in the range of $7.00 to $7.45. The company expects full-year 2022 net sales to be up mid-double digits and adjusted operating income to be up low-double digits.
Positive Outlook
- North America operating income is expected to be up low to mid-double digits, driven by favorable price mix.
- South America operating income is expected to now be up high double-digits, driven by favorable price mix.
- Asia-Pacific operating income is expected to now be up mid-single digits, driven by PureCircle growth.
- EMEA operating income is expected to now be flat to up low single-digits, driven by favorable price mix.
- Corporate costs are expected to be up mid-single digits.
Challenges Ahead
- The macro environment remains uncertain.
- The company faces inflationary and foreign exchange headwinds.
- There are ongoing supply chain challenges.
- Cash from operations for full-year 2022 is now expected to be in the range of $225 million to $275 million, which reflects an anticipated increase in our working capital balances due to higher corn costs.
- Capital expenditures for the full year are expected to be between $290 million and $320 million.